The online education courses aim to support Australian health professionals make informed decisions regarding cannabinoid therapeutics.
AusCann’s chairman Dr Mal Washer said: “It is essential that Australian doctors are informed about the endocannabinoid system and cannabinoid therapeutics so that they can make informed decisions regarding treatment possibilities.
“Until it becomes part of the medical syllabus, there is a need to provide accessible, referenced, objective information about cannabinoid medicines that doctors and other health professionals can draw upon to inform their thinking.”
AusCann’s chief medical advisor Dr Danial Schecter built an experienced team for the outreach program.
The online courses represent the latest component of that outreach program.
AusCann recently commenced trading on the US OTCQX Market under the stock symbol ACNNF.
Trading on the OTCQX supports AusCann’s strategy to broaden its international investor base, particularly in North America where it has a number of strategic agreements in place.